Preclinical Development of Oral Anthrax Vaccine
$165,000Y01FY2011AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
This contract supports final preclinical development of an oral anthrax vaccine candidate.
View original record on NIH RePORTER →